https://www.indianpharmapost.com/casper-pharma-completed-usfda-pre-approval-inspection-127572022-07-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-laboratories-enters-into-a-licensing-agreement-with-slayback-pharma-127582022-07-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/shilpa-medicares-unit-iii-advanced-analytical-characterization-laboratory-clears-us-fda-remote-record-review-127592022-07-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/cipla-posts-q1fy23-consolidated-pat-at-rs-68640-cr-127602022-07-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/torrent-pharmaceuticals-posts-q1fy23-consolidated-pat-rs-354-cr-127612022-07-31T00:00:00+05:30always0.9